STERIS (STE) PT Raised to $275 at Piper Sandler

August 7, 2026 7:56 AM

Piper Sandler analyst Jason Bednar raised the price target on STERIS (NYSE: STE) to $275.00 (from $270.00) while maintaining a Overweight rating.

No results found